Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.38M Hold
19,503
0.13% 138
2025
Q4
$6.38M Buy
19,503
+7,779
+66% +$2.47M 0.13% 138
2025
Q3
$3.31M Sell
11,724
-3,658
-24% -$1.06M 0.12% 157
2025
Q2
$4.29M Buy
+15,382
New +$4.36M 0.18% 129
2024
Q4
$1.45M Buy
5,582
+1,406
+34% +$417K 0.12% 177
2024
Q3
$1.35M Buy
4,176
+306
+8% +$100K 0.17% 122
2024
Q2
$1.21M Sell
3,870
-394
-9% -$116K 0.21% 97
2024
Q1
$1.21M Sell
4,264
-1,457
-25% -$426K 0.24% 92
2023
Q4
$1.65M Sell
5,721
-1,107
-16% -$302K 0.35% 75
2023
Q3
$1.84M Buy
6,828
+1,021
+18% +$255K 0.45% 52
2023
Q2
$1.29M Buy
5,807
+924
+19% +$214K 0.31% 79
2023
Q1
$1.18M Sell
4,883
-761
-13% -$187K 0.31% 78
2022
Q4
$1.48M Buy
5,644
+1,975
+54% +$529K 0.46% 47
2022
Q3
$827K Buy
3,669
+48
+1% +$11.6K 0.31% 66
2022
Q2
$881K Sell
3,621
-3
-0.1% -$735 0.34% 65
2022
Q1
$876K Buy
3,624
+1,091
+43% +$251K 0.33% 77
2021
Q4
$570K Buy
+2,533
New +$535K 0.15% 87

Other funds holding AMGN

Vise Technologies's AMGN Position: Q1 2026 in Review

Vise Technologies held its Amgen (AMGN) position steady in Q1 2026 at 19,503 shares worth $6.38M. The position accounts for 0.13% of the portfolio, ranked #138.

Vise Technologies first reported a position in AMGN in Q4 2021 and has held it in 17 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Vise Technologies held 19,503 shares of Amgen worth $6.38M as of Q1 2026.
  • Vise Technologies left its Amgen share count unchanged in Q1 2026.
  • Amgen made up 0.13% of Vise Technologies's portfolio in Q1 2026, its #138 holding.
  • Vise Technologies first reported a position in Amgen in Q4 2021 and has held it in 17 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.